Companies › TLSI
TRISALUS LIFE SCIENCES (TLSI)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001826667 · EDGAR filings · Updated 2026-07-07
TRISALUS LIFE SCIENCES (TLSI) has reported institutional ownership of 34.0%, with 85 institutional managers holding positions valued at $83.3M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-07 — SCHEDULE 13G/A filed
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Annual insider statement filed (Form 5)
- 2026-07-01 — Insider transaction reported (Form 4)
- 2026-07-01 — Annual insider statement filed (Form 5)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, TRISALUS LIFE SCIENCES has 85 institutional holders and institutional ownership of 34.0%.
Insider activity
Insiders reported 39 transactions (6 buys, 18 sells) across 11 reporting insiders, with a net reported value of $1.52M.
Data flags from SEC filings
Related companies
OMNIAB INC (OABI) · TILRAY BRANDS INC (TLRY) · SIGHT SCIENCES INC (SGHT) · EQUILLIUM INC (EQ) · GOSSAMER BIO INC (GOSS) · ADLAI NORTYE LTD (ANL)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-07.